DYN Institutional Ownership

DYNE THERAPEUTICS INC

Latest close $25.97 as of Aug 4, 2026

Create account to watch
Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices. Form 13F rows are quarter-end holding context only and do not establish an exact entry date.
Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes. Filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro. The overall institutional consensus preview remains public. Compare plans.
Cross-institution intelligence

Institutional Research

Each institution is compared with its own prior filing, then the latest institution-level directions are compared for breadth.

Latest filing Jul 28, 2026
Public consensus preview Broad accumulation 84/100 institutional research score
Multi-institution accumulation 3 tracked institutions Latest filing Jul 28, 2026

2 accumulating across 2 comparable institutions.

Accumulating2
Unchanged0
Reducing0
Exited0

The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.

Price context

52-week position is market context and does not change the institutional consensus score.

52-week low$8.06 52-week high$25.00
Latest close $25.97 100.0% through the range

Tracked institutions

Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.

Latest observation Jun 30, 2026
BlackRock Jul 28, 2026 filed
T. Rowe Price Investment Management May 15, 2026 filed
Fidelity / FMR May 6, 2026 filed
Detailed institutional research

See what is driving the consensus.

Unlock holder-by-holder changes, ownership history, breadth by period, disclosure timing, and filing-specific signal analysis.

Create free account Compare Investor and Pro

A free account adds watchlists and reveals tracker research gauges. Investor or Pro unlocks the detailed research above.

Beneficial ownership filing history

Showing 3 of 8 parsed filing(s) · 5 older require more history access
Holder Observed / filed Reported change Shares Ownership Observation Filing Latest
BlackRock CIK0002012383 Jun 30, 2026 observed Jul 28, 2026 filed · 28d Schedule 13G amendment Reported accumulation 11.5M +3.7M 12.00% +4.20 pts $22.21 $25.90 $25.97
T. Rowe Price Investment Management CIK0001897612 Mar 31, 2026 observed May 15, 2026 filed · 45d Schedule 13G amendment Reported accumulation 30.8M +4.2M 18.70% +2.50 pts $18.13 $17.29 $25.97
Fidelity / FMR CIK0000315066 Mar 31, 2026 observed May 6, 2026 filed · 36d Initial Schedule 13G Initial Schedule 13G 8.9K 12.00% $18.13 $18.84 $25.97
Explore more institutional activity

Related research

Crawlable links to other securities with similar institutional consensus or recent multi-institution accumulation.

Similar research strength

PCVX VAXCYTE INC 84/100 Broad accumulation LTBR LIGHTBRIDGE CORP 84/100 Broad accumulation HBNC HORIZON BANCORP INC/IN 84/100 Broad accumulation FMC FMC CORP 84/100 Broad accumulation

Recent multi-institution accumulation

TVTX TRAVERE THERAPEUTICS INC 2 accumulating Aug 6, 2026 VVX V2X INC 2 accumulating Aug 6, 2026 VSEC VSE CORP 3 accumulating Jul 31, 2026 RXRX RECURSION PHARMACEUTICALS-A 2 accumulating Jul 31, 2026